Credentialized Authorized Trading
Partner Status under

The Drug Supply Chain Security Act (DSCSA) requires US pharmaceutical supply chain actors to prove that they only interact with trading partners that are “authorized”. Trading partners are “authorized” when they hold state licenses valid at the time of trading.

Proof of electronically authorized status is required in every Saleable Return Verification process where wholesalers and their customers (dispensers such as hospitals, pharmacies and other points-of-dispensing) must be able to verify the validity of drugs and be able to uniformly identify products as legitimate or illegitimate. To check the counterparties’ “authorized” status, pharma companies can use the identity wallet technology.

Spherity is working together with global pharmaceutical manufacturers, wholesalers, distributors, the Healthcare Distribution Alliance and other solution providers to develop a production-grade solution for the Authorized Trading Partner legislation by Autumn 2020. Spherity’s Cloud Identity Wallet enables the exchange and verification of electronic state licenses.


  • Automated and electronic verification of state licenses in Saleable Return Process
  • No change in existing processes or industry standards required
  • Technology can be extended on product level to meet traceability requirements of DSCSA by 2023


  • Trading partner can request and store state licenses from credential issuer
  • Credential issuer signs and issues state licenses directly as Verifiable Credentials
  • Trading partners or service providers can present, request and verify credentials in real-time




Project Scope
DSCSA-Compliant Verification of Authorized Trading Partners


Organization Size
+ 100.000 Employees


Client Testimonial

“Based on our successful collaboration with Spherity, the industry agreed to further investigate the usage of W3C Decentralized Identifiers and Verifiable Credentials technology to electronically verify Authorized Trading Partners in the saleable returns verification process in an industry-wide pilot.”


Dr. Oliver Nuernberg
Chief Product Owner, SAP Life Sciences

Stay sphered, join our Newsletter

Consider what decentralized identity management
could mean for the visibility and trustworthiness of data
throughout your business processes.